The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...
Average learning hours With AI and Big Data requiring fewer than half the learning hours of programming to reach beginner ...
The Telecommunication Engineering Centre (TEC) and IIT Kanpur have signed an MoU to focus on developing India-specific ...
A Competitive Takeout Program designed to help organizations escape the high cost and complexity of legacy metadata ...
Kerala Vigilance Department's Operation Barcode inspects Kannur bars for serving short measures and unauthorised liquor. Find ...
Authored by Karthik Chandrakant, this foundational resource introduces readers to the principles and potential of AI. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.
Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow.Partnership introduces CardioYield powered by MaxYield for automated, reliable Holter ...
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback